The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 2nd 2024
The 11 to 3 vote against the benefit-risk profile of sotagliflozin comes with less than 2 months to go until the December 20, 2024 PDUFA date.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
JAMA Review Details Current Evidence Base Surrounding Intermittent Fasting for Weight Loss
December 17th 2021An umbrella review of meta-analyses of RCTs examining intermittent fasting for weight loss provide a comprehensive overview of the effects of the approach on various health outcome measures in patients with overweight or obesity.
Hypertension in Pregnancy Could Signal Increased Heart Failure Risk
December 16th 2021An analysis of the Women's Health Initiative suggests hypertensive disorders of pregnancy were associated with a significant increase in risk for incident heart failure, but this association was not observed for other adverse pregnancy outcomes.
Bariatric Surgery Associated with Lower Cancer Risk in Obesity and Diabetes
December 8th 2021Analysis of data from the SOS study indicates bariatric surgery was associated with a 37% reduction in incident cancer among individuals with obesity and diabetes versus conventional obesity treatments, with those achieving diabetes remission experiencing a 60% reduction in risk.
Bariatric Surgery Dramatically Lowers Liver, Cardiovascular Risk in Patients with NASH
November 23rd 2021Undergoing bariatric surgery was associated with reductions in risk of adverse liver outcomes and MACE versus nonsurgical management among patients with obesity and biopsy-proven nonalcoholic steatohepatitis in the SPLENDOR study.
Doctors Weigh Cardiovascular Risk Reduction Over Side Effects for Antihyperglycemic Agents
The least selected attributes were food and medication restrictions and A1c lowering followed by risk of diabetic ketoacidosis, risk of genital infection, and the avoidance of severe hypoglycemia.